Deira Trading Company
Eisai shares fell sharply after its Alzheimer’s drug failed to secure marketing approval in the European Union.
Your email address will not be published. Required fields are marked *
Comment *
Name *
Email *
Website
Save my name, email, and website in this browser for the next time I comment.